Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT00140829

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

View on ClinicalTrials.gov

Summary

Cerebellar ataxias (CA) and spastic paraplegias (SP) are genetically and clinically very heterogeneous. More than 40 loci are already known but the number of phenotypes is even greater suggesting further genetic heterogeneity. These progressive disorders are often severe and fatal, due to the absence of specific therapy. The SPATAX network combines the experience of European clinicians and scientists working on these groups of diseases. Over the past year, they have assembled the largest collection of families and achieved a number of tasks (initiation of a clinical and genetic database, distribution of DNA to participating laboratories, mapping of three new loci, and refinement of several loci). In addition to clinicians from Europe and Mediterranean countries, who play a major role in collecting families according to evaluation tools developed and validated by the SPATAX members, the group includes major European laboratories devoted to the elucidation of the molecular basis of these disorders. Each laboratory will centralize all families with a subtype of autosomal recessive (AR) CA (n=116) or SP (n=207) in order to efficiently map and identify the responsible gene(s). Genome-wide scans are already underway in 61 families. Given the expertise of the participants, the researchers expect to map and identify several genes during the course of this project. The spectrum of mutations and phenotype/genotype correlations will be analysed thanks to this unique series of patients with various phenotypes. The knowledge gained will be immediately applicable to patients in terms of improved positive diagnosis, follow-up and appropriate genetic counselling. In the long term, models for genetic entity will be developed in order to understand the pathophysiology and to identify new targets for treatment. The series of patients assembled and the precise knowledge of natural history will facilitate the implantation of therapeutic trials based on rational approaches.

Official title: Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias

Key Details

Gender

All

Age Range

2 Years - 70 Years

Study Type

OBSERVATIONAL

Enrollment

6000

Start Date

2004-02-10

Completion Date

2020-12-30

Last Updated

2026-10-02

Healthy Volunteers

Yes

Locations (27)

CHU Mustapha

Algiers, Algeria

Université Libre de Bruxelles - Hôpital Erasme

Brussels, Belgium

The Panum Institute

Copenhagen, Denmark

CHU d'Angers

Angers, France

Hôpital Pellegrin

Bordeaux, France

Hôpitaux de Clermont-Ferrand

Clermont-Ferrand, France

CHU

Grenoble, France

Hôpital de la Timone

Marseille, France

Hôpital Carémeau

Nîmes, France

Hôpital Armand Trousseau

Paris, France

Pitié-Salpêtrière Hospital

Paris, France

Hôpital Charles Nicolle

Rouen, France

Hôpital Purpan

Toulouse, France

Hadassah-Hebrew University Hospital

Jerusalem, Israel

Dipartimento Di Scienze Neurologiche

Naples, Italy

Molecular Medicine and Department of Neurosciences

Roma, Italy

Université Saint-Joseph

Beirut, Lebanon

CHU de Rabat

Rabat, Morocco

Radboud University Nijmegen Medical Centre

Nijmegen, Netherlands

Ullevål University Hospital

Oslo, Norway

University of Porto

Porto, Portugal

Hospital San Sebastião

Santa Maria da Feira, Portugal

King Khalid University Hospital

Riyadh, Saudi Arabia

Clinical Centre of Serbia

Belgrade, Serbia

Hôpital Habib Bourguiba

Sfax, Tunisia

Royal Free and University College Medical School

London, United Kingdom

The National Hospital

London, United Kingdom